Sunovion Pharmaceuticals Inc. is a pharmaceutical company that manufactures a range of prescription medications, primarily focusing on treatments for respiratory and central nervous system disorders.
Key Medications Manufactured by Sunovion
Based on NDC labeler information, Sunovion Pharmaceuticals Inc. is associated with the manufacturing of several distinct drugs. These include respiratory medications for conditions like asthma and COPD, as well as other therapeutic agents.
The following table details some of the drugs made by Sunovion:
| NDC Code | Trade Name | Manufacturer |
|---|---|---|
| 63402-0701 | Omnaris | Sunovion Pharmaceuticals Inc. |
| 63402-0815 | SEEBRI NEOHALER | Sunovion Pharmaceuticals Inc. |
| 63402-0681 | UTIBRON NEOHALER | Sunovion Pharmaceuticals Inc. |
| 63402-0511 | Xopenex | Sunovion Pharmaceuticals Inc. |
- Omnaris is a nasal spray typically used to treat symptoms of seasonal and perennial allergic rhinitis.
- SEEBRI NEOHALER (glycopyrrolate) and UTIBRON NEOHALER (indacaterol and glycopyrrolate) are bronchodilators used for the long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD).
- Xopenex (levalbuterol) is a short-acting beta-agonist (SABA) used to treat or prevent bronchospasm in patients 6 years of age and older with reversible obstructive airway disease, such as asthma.
For more information on drug products and their manufacturers, resources like the NDC Database can be helpful.
